US Patent 11834669 Recombinant cytomegalovirus vectors as vaccines for tuberculosis
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+36 properties)
Article (+339 characters)
US Patent 11834669 Recombinant cytomegalovirus vectors as vaccines for tuberculosis
Article
Patent abstract
Disclosed herein are cytomegalovirus vectors encoding fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, cytomegalovirus vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
Infobox
Is a
Patent Jurisdiction
Patent Number
Patent Inventor Names
Aurelio M. Bonavia0
Dominick J. Laddy0
Guangwu Xu0
Louis Picker0
Ravi Anantha0
Scott Hansen0
Thomas G. Evans0
Date of Patent
December 5, 2023
0Patent Application Number
173655090
Date Filed
July 1, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11834669 Recombinant cytomegalovirus vectors as vaccines for tuberculosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
